1st SERbian BIomarker Symposium (SERBIS)

 

WELCOME ADDRESS

 

Dear Colleagues and Friends,

 

It is a great pleasure and honor to invite you to the 1^st SERbian BIomarker Symposium  (SERBIS) that will be held in Belgrade, Serbia, on January 28-29, 2016. This international symposium is arranged to bridge clinical and laboratory work, emphasising the importance of teamwork and interactions between all professionals involved in the fight against cardiovascular disease and personalized medicine approache. The 1st SERBIS with the overall theme Biomarkers in Clinical Cardiology: Diagnosis, Treatment and Devices is intended to display the state of the biomarker use at the interface between Cardiology and Laboratory Medicine.

 

This symposium will bring together well-known experts from all-over Europe which will share their knowledge, experience, latest research and deliver state-of-the-art lectures in the area of clinical cardiology, circulating and imaging biomarkers, advances in analytical issues, recently published guidelines and evidence based therapies and treatment strategies.

 

We were planning an innovative and original programme to present, share, debate and conclude on the opportunity to improve diagnosis, risk stratification, and selection of therapy using noninvasive new biomarkers and new application of existing biomarkers in clinical cardiology.

 

We are convinced that SERBIS will be top level educational and scientific event in our region, giving to the participants an excellent opporunity for education and chance for improvement of personal achievements. It will offer a unique opportunity to identify new research ideas and establish collaboration with colleagues from different countries. Also, to keep up to date with Industry partners who will showcase their latest advances on their booths in biomarkers determination, therapy and devices in clinical cardiology.

 

We hope that SERBIS will meet your expectations, provide you some unforgettable personal and professional memories, and trust that you will enjoy your visit to the very beautiful and exciting city of Belgrade.

 

We look forward to welcoming you in Belgrade.

 

Sincerely yours,

Symposium directors
 

5 SLIKA

 

 

ORGANIZER

Clinical Center of Serbia

Center for Medical Biochemistry

Department of Cardiology

 

COORGANIZERS

Cardiology Section of the Serbian Medical Association

Board on Cardiovascular Pathology of the Serbian Academy of Sciences and Arts

 

HONORARY COMMITTEE

 

Ass. dr Zlatibor Lončar

 Minister of Health of the Republic of Serbia

 

Dr Srđan Verbić

 Minister of Education, Science and Technological Development of the Republic of Serbia

 

Academician Vladimir Kostić

President of Serbian Academy of Sciences and Arts

 

Academician Dragan Micić

President of Serbian Health Council

 

Academician Vladimir Kanjuh

President, Board on Cardiovascular Pathology of the Serbian Academy of Sciences and Arts

 

Academician Ljubiša Rakić

President, Board on Biomedical Investigation of the Serbian Academy of Sciences and Arts

 

Academician Radoje Čolović

President of Serbian Medical Association

 

Academician Vladimir Bumbaširević

Rector, University of Belgrade

 

Academician Jovan Hadži-Đokić

 

Academician Nebojša Lalić

Dean, University of Belgrade, School of Medicine

 

Prof. dr Zorica Vujić

Dean, University of Belgrade, School of Pharmacy

 

 

 

 

 

SCIENTIFIC COMMITTEE

 

Milika Ašanin

Tobias Breidthardt

Benjamin Dieplinger

Dragan Dinčić

Damien Gruson

Angelika Hammerer-Lercher

Branislava Ivanović

Vladimir Kanjuh

Gabor Kovacs

Paivi Laitinen

Nebojša Lalić

Vangelis Manolopoulos

Iacoviello Massimo

Christophe Meune

Goran Milašinović

Igor Mrdović

Aleksandar Nešković

Slobodan Obradović

Mauro Panteghini

Milan Pavlović

Tatjana Potpara

Kari Pulkki

Arsen Ristić

Ron H.N. van Schaik

Petar Seferović

 Grazyna Sipniewska

Salvatore Di Somma

Goran Stanković

Sanja Stanković

Branislav Stefanović

Dragana Šobić-Šaranović

Raphael Twerenbold

Vladan Vukčević

 

 

 

 

 

 

 

 

 

 

 

 

 

ORGANIZING COMMITTEE

 

Daniela Bartolović

Branko Beleslin

 Andjelo Beletić

Jasna Bjelanović

Emina Čolak

Ana Djordjevic-Dikić

 Anica Djordjević

Jelica Djordjević

Radica Dunjić

Olja Gabrić

Dimitra Kalimanovska-Oštrić

 Mirjana Milivojević

Predrag Mitrović

 Ivana Nedeljković

Milan Nedeljković

 Biljana Obrenović-Kirćanski

 Radmila Obrenović

Dejan Orlić

 Milan Petrović

 Dragan Simić

 Jelena Stepanović

 Vesna Stojanov

 Siniša Stojković

Gordana Stošić

Tatjana Vodnik

Bosiljka Vujisić-Tešić

Dragana Vukosavljević

 

 

UNDER THE AUSPICES OF

Ministry of Health of the Republic of Serbia

Ministry of Education, Science and Technological Development of Serbia

 

 

 

 

 

 

 

 

	THURSDAY, JANUARY 28, 2016
08:30 -10:00	Registration
10:00-10:30	Opening ceremony
	BIOMARKERS AND EVIDENCE-BASED MEDICINE
	Chairs: Mauro Panteghini, Ron H.N. van Schaik, Goran Stanković
10:30 -10:50	Biomarkers in recent international guidelines		Salvatore Di Somma	Rome, Italy
10:50 -11:10	Critical aspects of cardiac troponin use in clinical practice		Mauro Panteghini	Milano, Italy
11:10 -11:30	The use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe: The CARMAGUE study		Paivi Laitinen	Helsinki, Finland
11:30-11:50	Genetic biomarkers for optimizing drug therapy: the clinical value of pharmacogenetics		Ron H.N. van Schaik	Rotterdam, Netherlands
11:50-12:10	Pharmacogenomics of cardiovascular drugs		Vangelis Manolopoulos	Alexandroupolis, Greece
12:10-12:30	Q&A (Discussion)
12:30-13:00	Coffee break
	BIOMARKERS FOR HEART FAILURE
	Chairs: Salvatore di Somma, Petar Seferović, Sanja Stanković
13:00-13:20	ESC Guideline strategies for biomarkers use to guide management of heart failure patients		Petar Seferović  106252	Belgrade, Serbia
13:20-13:40	Natriuretic peptides in clinical practice		Tobias Breidthardt	Basel, Switzerland
13:40-14:00	How to improve heart failure management by using galectin-3?		Iacoviello Massimo	Bari, Italy
14:00-14:20	The role for novel biomarkers, ST2 and GDF-15, for diagnosis, risk assessment and/or therapeutic guidance in heart failure		Sanja Stanković	Belgrade, Serbia
14:20-14:40	Prognosis of heart failure: perspectives from the FGF-23/PTH/ Vitamin D axis		Damien Gruson	Brussels, Belgium
14:40-15:00	Copeptin in acute coronary syndromes and heart failure management: state of the art and future directions		Angelika Hammerer Lercher	Aarau, Switzerland
15:00-15:15	Q&A (Discussion)
15:15-15:45	Lunch symposium-Bayer
	NOVEL ANTITHROMBOTIC AND ANTICOAGULATION THERAPY
	Chairs: Goran Milašinović, Aleksandar Nešković, Branislava Ivanović
16:00-16:20	Ticagrelor: patients selection and optimal timing of initiation		Slobodan Obradović	Belgrade, Serbi
16:20-16:40	DAPT: optimal duration and monitoring		Aleksandar Nešković 108476	Belgrade, Serbia
16:40-17:00	Ventricular arrhythmias and prevention of sudden cardiac death		Goran Milašinović 106055	Belgrade, Serbia
17:00-17:20	Novel anticoagulation therapy in atrial fibrillation		Tatjana Potpara	Belgrade, Serbia
17:20-17:40	Novel anticoagulation therapy in prevention of deep venous thrombosis and pulmonary embolism		Branislava Ivanović 106103	Belgrade, Serbia
17:40-18:00	Triple therapy following myocardial revascularization: who, when, and how?		Milan Pavlović	Niš, Serbia
18:00-18:15	Q&A (Discussion)
	FRIDAY, JANUARY 29, 2016
09:15-09:45	Symposium-Mylan
	BIOMARKERS FOR ACUTE CORONARY SYNDROMES
	Chairs: Nebojša Lalić, Christophe Meune, Grazyna Sipniewska
10:00-10:20	Biomarkers in risk stratification and management of patients with diabetes and metabolic syndrome		Nebojša Lalić 100368	Belgrade, Serbia
10:20-10:40	Short-term risk stratification for cardiac patients: emergency department and cardiology perspectives		Christophe Meune	Paris, France
10:40-11:00	Innovative approach to diagnosing acute myocardial infarction in 1-hour with high-sensitive cardiac troponin T		Raphael Twerenbold	Basel, Switzerland
11:00-11:20	Paradigm Change with high sensitivity troponin assays		Benjamin Dieplinger	Linz, Austria
11:20-11:40	High-sensitive troponins: analytical perspectives		Grazyna Sipniewska	Bydgoszcz, Poland
11:40-12:00	Troponin POCT assays in the diagnosis of myocardial infarction		Gabor Kovacs	Pécs, Hungary
12:00-12:20	Utility of H-FABP for the early diagnosis of acute coronary syndrome		Kari Pulkki	Kuopioo, Finland
12:20-12:45	Q&A (Discussion)
12:45-13:45	Lunch
	BIOMARKERS AND MYOCARDIAL REVASCULARIZATION
	Chairs: Vladimir Kanjuh, Dragana Šobić-Šaranović, Dragan Dinčić
14:00-14:20	Vulnerable plaque or vulnerable patient		Vladimir Kanjuh	Belgrade, Serbia
14:20-14:40	Integrated imaging in the selection of patients for myocardial revascularization		Dragana Šobić-Šaranović 105797	Belgrade, Serbia
14:40 -15:00	Controversies in defining periprocedural myocardial infarction		Goran Stankovic 101015	Belgrade, Serbia
15:00-15:20	Secondary prevention after myocardial revascularization		Dragan Dinčić 104980	Belgrade, Serbia
15:20-15:30	Q&A (Discussion)
15:30-16:00	Symposium- Astra Zeneca (kafa)
	NEW GUIDELINES IN 2014/15: KEY MESSAGES FOR CLINICAL PRACTICE
	Chairs:Arsen Ristić, Branislav Stefanović, Igor Mrdović
16:15-16.35	Differential diagnosis of acute chest pain		Vladan Vukčević  106224	Belgrade, Serbia
16:35-16:55	Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation		Igor Mrdović 106096	Belgrade, Serbia
16:55-17:15	Pulmonary embolism		Branislav Stefanović 106226	Belgrade, Serbia
17:15-17:35	Pericardial disease & pulmonary hypertension		Arsen Ristić  106253	Belgrade, Serbia
17:35-18:00	Summary and closing of the symposium

 

 

 

 

 

SYMPOSIUM VENUE

 

Hyatt Regency Belgrade is the finest ***** 5 star hotel in Belgrade.

Hotel address is Milentija Popovića 5 Street, 11 070 Belgrade, Serbia, phone +381 11 301 1234, fax +381 11 311 2234, e-mail belgrade.regency@hyatt.com, web link www.hyattregencybeograd.rs

 

GENERAL INFORMATION

 

CURRENCY

The Serbian currency is Serbian Dinar (abbreviated as RSD). Current exchange rate is about 121 RSD for 1 Euro. Credit cards (VISA, Euro card, MasterCard, American Express, Diners Club) are accepted in most shops. Automated Teller Machines (ATMs) and Exchange offices are also available in the Hotel. For detailed information contact Hotel reception.

 

PUBLIC TRANSPORTATION

Bus lines 68, 95, as well as tram lines 7, 7L, 9, 11 and 13 connect the Hotel with the City. The one way tickets are available in the buses and trams (cost 150 RSD, app. 1.2 Euro), and also the multiple use tickets can be acquired at kiosks in the front of the Center. Taxis are available throughout the City of Belgrade, and also in front of the Hotel.

 

WiFi

Free WiFi is provided for al Symposium participants. Choose option Hyatt internet, than option Conference, input code: meet/serbis thick terms of use and the end click authenticate.

 

WEATHER FORCAST

During the two days of the Symposium mostly cloudy weather is expected, and daily temperatures ranging from 0-3 °C (source: accuweather.com).  

 

SCIENTIFIC SECRETARIAT

Sanja Stanković, Goran Stanković, Arsen Ristić, Branislava Ivanović,  Clinical Center of Serbia,  Višegradska 26, 11000 Belgrade, Serbia, Phone/Fax: +381-11-361-5631, E-mail: cmb@kcs.ac.rs, Mobile phones: +381-66-8300-598 (Sanja Stanković), +381-66-8300-302 (Goran Stanković), +381-66-8300-340 (Arsen Ristić), +381-66-8300-352 (Branislava Ivanović).

 

TRAVEL AGENCY

For hotel reservations and travel arrangements please contact TCA travel agency (Ms. Radmila Kovačević or Ms. Katarina Kovačević, office phone +381-11-3238-514 or +381-11-3238-705, or mobile phone +381-063-300-719, E-mail: tca@beotel.net). Accommodation of the faculty members and international participants is organized at the Hyatt Regency Hotel. Transportation from the airport and from the hotels will be organized for all invited speakers and international participants.

 

LANGUAGE

The official language of the Symposium is English.

 

REGISTRATION

Registration desk will be opened on Thursday January 28th 2016, from 8:30 AM. Registration fee for participants is free of charge. Preregistered participants can pick up their name badges and Symposium material at the Registration desk from Thursday January 28th 2016, 8:30 AM.  Symposium speaker’s abstracts will be available at Symposium web site http://www.serbis.rs/.

 

CERTIFICATES OF ATTENDANCE

The Symposium program is accredited by the Medical Council of Serbia with 9 CME credit hours for participants and 15 for lecturers (No. 153-01-3890/2015-01, Ev.No. А-1-3176/15). Certificates of attendance will be available at the Registration Desk, on Friday, January 29, 2016 from 06:00 PM.

 

DOWLOAD PROGRAM FROM THE SYMPOSIUM WEBSITE: http://www.serbis.rs/

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PRINCIPAL SPONSOR

 

PLATINUM SPONSOR

ASTRA                  BAYER

 

GOLD SPONSOR

ABBOTT            INTERLAB        LABTEH

 

 SILVER SPONSOR

ACTAVIS    ADOC  BIOMERIEUX    MERCK  PFIZER                     

SPONSORS OF SCIENTIFIC SYMPOSIA

   MYLAN

SPONSORS

ALKALOID    ALURA  BOEHRINGER KRKA

PHARMASWISS  SUPERLAB